Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study to Evaluate the Safety and Efficacy of a Single Tablet Regimen of Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate Compared With a Single Tablet Regimen of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults

ClinicalTrials.gov ID: NCT01309243

Public ClinicalTrials.gov record NCT01309243. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 8:23 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3B, Randomized, Open-label Study to Evaluate the Safety and Efficacy of a Single Tablet Regimen of Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate Compared With a Single Tablet Regimen of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of the study was to evaluate the safety and efficacy of the emtricitabine (FTC)/rilpivirine (RPV)/tenofovir disoproxil fumarate (TDF) single-tablet regimen (STR) compared with the efavirenz (EFV)/FTC/TDF STR in HIV-1 infected adults who had not previously received treatment with antiretroviral medications. Participants were randomized in a 1:1 ratio to receive one of the study treatments. Randomization was stratified by HIV-1 RNA level (≤ 100,000 copies/mL or \> 100,000 copies/mL) at screening. A treatment duration of 96 weeks was planned, with the option for subjects in FTC/RPV/TDF STR arm to receive treatment following the Week 96 visit until FTC/RPV/TDF STR is commercially available or until Gilead Sciences elects to terminate development in that country.

Study identification

NCT ID
NCT01309243
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Gilead Sciences
Industry
Enrollment
799 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 2011 (Type not available)
Primary completion
Sep 2012 (Actual)
Completion
Feb 2014 (Actual)
Last update posted
Feb 25, 2015

2011 – 2014

United States locations

U.S. sites
83
U.S. states
25
U.S. cities
62
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35294 —
Spectrum Medical Group Phoenix Arizona 85012 —
AHF Research Center Beverly Hills California 90211 —
Kaiser Permanente Medical Center Hayward California 94545 —
Living Hope Education and Research Consultants Long Beach California 90813 —
Kaiser Permanente Medical Center Los Angeles California 90027 —
Jeffrey Goodman Special Care Clinic/Los Angeles Gay and Lesbian Center Los Angeles California 90028 —
Lightsource Medical Los Angeles California 90036 —
Cedars-Sinai Medical Center Los Angeles California 90048 —
Oasis Clinic Los Angeles California 90059 —
Anthony Mills MD Inc Los Angeles California 90069 —
Orange Coast Medical Group Newport Beach California 92663 —
East Bay AIDS Center Oakland California 94609 —
Stanford University Palo Alto California 94304 —
University of California, Davis Sacramento California 95817 —
Kaiser Permanente Medical Group Sacramento California 95825 —
La Playa Medical Group and Clinical Research San Diego California 92103 —
Metropolis Medical/Dr.Fritz San Francisco California 94114 —
Kaiser Permanente Medical Center, San Francisco San Francisco California 94118 —
Apex Research LLC Denver Colorado 80209 —
Dupont Circle Physician's Group Washington D.C. District of Columbia 20009 —
Whitman-Walker Clinic Washington D.C. District of Columbia 20009 —
Capital Medical Associates, PC Washington D.C. District of Columbia 20036 —
Medical Faculty Associates Washington D.C. District of Columbia 20037 —
Broward General Medical Center Fort Lauderdale Florida 33311 —
Gary J. Richmond, M.D., P.A. Fort Lauderdale Florida 33316 —
Midway Immunology and Research Center Ft. Pierce Florida 34982 —
The Kinder Medical Group Miami Florida 33133 —
Wohlfeiler, Piperato and Associates, LLC Miami Beach Florida 33139 —
Orlando Immunology Center Orlando Florida 32803 —
Valuhealthmd,Llc / Idocf Orlando Florida 32806 —
Infectious Disease Associates of NW FL Pensacola Florida 32504 —
AHF Health Positive - Tampa Bay Safety Harbor Florida 34695 —
St. Joseph's Hospital d/b/a Comprehensive Research Institute Tampa Florida 33614 —
Emory University Atlanta Georgia 30306 —
AIDS Research Consortium of Atlanta Atlanta Georgia 30308 —
Atlanta ID Group Atlanta Georgia 30309 —
Infectious Disease Specialists of America Decatur Georgia 30033 —
Mercer University School of Medicine Macon Georgia 31201 —
Clint Spencer Clinic Honolulu Hawaii 96813 —
Northwestern University Chicago Illinois 60611 —
Howard Brown Health Center Chicago Illinois 60613 —
Northstar Medical Center Chicago Illinois 60657 —
Johns Hopkins Rockland Physicians Practice and Research Group at Greenspring Station Lutherville Maryland 21093 —
Community Research Initiative of New England Boston Massachusetts 02111 —
Claudia T Martorell, MD., LLC dba The Research Institute Springfield Massachusetts 01105 —
Be Well Medical Center Berkley Michigan 48072 —
Henry Ford Health System Detroit Michigan 48202 —
Hennepin County Medical Center Minneapolis Minnesota 55415 —
Central West Clinical Research, Inc. St Louis Missouri 63108 —
Southampton Healthcare St Louis Missouri 63139 —
Saint Michael's Medical Center Newark New Jersey 07102 —
South Jersey Infectious Disease Somers Point New Jersey 08244 —
Southwest Care Center Sante Fe New Mexico 87505 —
Upstate Infectious Disease Associates Albany New York 12208 —
New York Hospital Queens Flushing New York 11355 —
North Shore University Hospital--Division of Infectious Diseases Manhasset New York 11030 —
Greiger Clinic Mount Vernon New York 10550 —
Beth Israel Medical Center New York New York 10003 —
Ricky K. Hsu, Md, Pc New York New York 10011 —
Montefiore Medical Center The Bronx New York 10467 —
Clinical and Translational Research Center - UNC Hospitals Chapel Hill North Carolina 27599 —
Carolinas Medical Center Charlotte North Carolina 28207 —
Duke University Medical Center Durham North Carolina 27710 —
The Brody School of Medicine at East Carolina University Greenville North Carolina 27834 —
Rosedale Infectious Diseases Huntersville North Carolina 28078 —
Wake Forest University Health Sciences Winston-Salem North Carolina 27157 —
Summa Health System Care Center Akron Ohio 44203 —
Hospital of the University of Pennsylvania Philadelphia Pennsylvania 19104 —
Philadelphia FIGHT Philadelphia Pennsylvania 19107 —
University of South Carolina Columbia South Carolina 29223 —
Central Texas Clinical Research Austin Texas 78705 —
Trinity Health and Wellness Center Dallas Texas 75208 —
Southwest Infectious Disease Associates, Inc. Dallas Texas 75219 —
Tarrant County Infectious Disease Associates Fort Worth Texas 76104 —
Garcia Family Health Group Harlingen Texas 78550 —
Therapeutic Concepts, P.A. Houston Texas 77004 —
Gordon E. Crofoot MD PA Houston Texas 77098 —
DCOL Center for Clinical Research Longview Texas 75605 —
CARE-ID Annandale Virginia 22003 —
Peter Shalit, M.D. Seattle Washington 98104 —
Rockwood Pulmonary and Critical Care Spokane Washington 99204 —
Medical College of Wisconsin Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 68 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01309243, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 25, 2015 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01309243 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →